Welcome to Cancer.fr

Welcome to the French National Cancer Institute’s website "Cancer.fr": France’s leading source for trustworthy information on cancer.

Welcome to the French National Cancer Institute’s website "Cancer.fr": France’s leading source for trustworthy information on cancer.

Who are we?

The French National Cancer Institute (INCa) is a State health and science agency specialising in cancer control created on 9 August 2004. It operates under the dual supervision of the Ministry of Health and the Ministry of Research.

We are a centre of expertise and resources aiming to enhance coordination among all stakeholders involved in the fight against cancer.

We act as an interface for patients, their families, healthcare system users, the general public, healthcare professionals, researchers, experts, and decision-makers, facilitating progress in cancer care.

We carry an integrated approach that works across all aspects of cancer control – health, scientific, social, and economic – as well as intervention areas such as prevention, screening, care, and research.

We lead the national effort to reduce the burden of cancer in our country. Thus, we ensure the implementation of France’s ten-year cancer control strategy. This ambitious strategy builds upon previous Cancer Plans and continues the collective mobilisation against this disease.

Our vision

Every year, more than 430,000 people in France are diagnosed with cancer, which remains the leading cause of mortality in our country. The rising number of cases largely due to ageing and increasing population, improved survival rates with significant and debilitating long-term sequels intensify cancer's impact on our society. 

Yet, real progress has been made: more than half of all cancers can now be cured. Current knowledge of prevention (more than 40-percent of cancer cases are linked to modifiable risk factors) also brings hope: overcoming cancer is no longer a utopian dream.

Our resources

The Institute has an annual budget of approximately €130 million, two-thirds of which is allocated to research funding. The remainder is dedicated to healthcare initiatives, data science, public health and public information. 

Our Institute employs 161 highly dedicated and expert staff.

Our latest publications